Amy Armstrong, MD

Pediatric Hematologist/Oncologist

Amy Armstrong

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Siteman Kids at St. Louis Children’s Hospital

Siteman Kids at St. Louis Children’s Hospital

On WashU Medicine Campus
1 Children's Place, St. Louis, MO 63110

Expertise & Training

Video thumbnail for Dr. Amy Armstrong, MD

Watch video on YouTube

Dr. Amy Armstrong, MD

6 mins

Dr. Amy Armstrong, MD Assistant Professor of Pediatrics, Division of Hematology and Oncology, Washington University School of Medicine at Siteman Cancer Center

Clinical Expertise

  • Pediatric cancers, solid tumors, adolescent and young adult sarcoma, NF-1 related malignancies

Primary Academic Title

Associate Professor of Pediatrics, Division of Hematology and Oncology, WashU Medicine

Board Certification

  • 2015: American Board of Pediatrics
  • 2019: American Board of Pediatrics (Hematology and Oncology)

Training

  • 2012 - 2015: Intern and Resident, Pediatrics, Northwestern University, Chicago, IL

Education

  • 2012: MD, Virginia Commonwealth University, Richmond, VA

Research & Selected Publications

Research Interest

Pediatric cancers

Research Publications

Neurofibromatosis type 1-plexiform neurofibromas: Integrating treatment across pediatric and adult populations
Authors:

Armstrong AE, Gross AM, Klesse LJ, one or more additional authors omitted Hirbe AC

Journal & Year:

Neuro-oncology | 2026

Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Authors:

Balis F, Green DM, Armstrong A, one or more additional authors omitted Sliker B

Journal & Year:

J Natl Compr Canc Netw | 2025

Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies
Authors:

Armstrong AE, Daw NC, Renfro LA, one or more additional authors omitted Dome JS

Journal & Year:

Cancer | 2025

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
Authors:

Sundby RT, Szymanski JJ, Pan AC, one or more additional authors omitted Armstrong AE, one or more additional authors omitted Shern JF

Journal & Year:

Clin Cancer Res | 2024

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Authors:

Zhao Z, Patel PA, Slatnick L, one or more additional authors omitted Armstrong A, one or more additional authors omitted Esbenshade AJ

Journal & Year:

J Clin Oncol | 2024

Sustained Response with Dose-reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid Carcinoma
Authors:

Suydam AC, Bach A, Markovina S, one or more additional authors omitted Armstrong AE

Journal & Year:

J Pediatr Hematol Oncol | 2023